NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...
3 Important Tips For Immuno-Oncology Drug Treatment
Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are brought into remission by the IO-based immunotherapy. IO drugs work…...
Biosimilar Drugs: Lowering the Cost of Cancer Care?
The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are all examples of biologics.2 These…...
Childhood Cancer Treatment by NFCR Partner Receives Fast Track Review and More Good News From the FDA
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, recently announced that the Unites States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to volasertib, one of its drugs. Volasertib is a small molecular inhibitor that has been…...
Mastectomy and Breast Reconstruction: What Breast Cancer Patients Should Know
Mastectomy is just one of the treatment options available to breast cancer patients. Learn more about what to expect before, during, and after the procedure, as well as some tips to help you prepare. A breast cancer diagnosis can be devastating, and navigating potential treatment options can be stressful and…...
Project Patient Voice – Helping Patients in the Fight Against Cancer
The U.S. Food and Drug Administration (FDA) recently launched a new initiative aimed to help patients in the fight against cancer. This project, appropriately named Project Patient Voice, was initiated by the FDA’s Oncology Center of Excellence to give patients and health care professionals unique information that has not been publicly…...